NFκB and glucocorticoid receptor activity in steroid resistance

Journal of Receptors and Signal Transduction

Volumn 32, Issue 1, 2012, Pages 29-35

  Dawson, Charlotte ^a   Dhanda, Ashwin ^b   Conway Campbell, Becky ^b   Dimambro, Alexandra ^b   Lightman, Stafford ^b   Dayan, Colin ^c  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

B promoter element; Glucocorticoid response element; Inflammatory cytokine; P65 NF B subunit; Peripheral blood mononuclear cell

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHYTOHEMAGGLUTININ; TRANSCRIPTION FACTOR RELA;

ADULT; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; DNA BINDING; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NUCLEUS ACCUMBENS; PERIPHERAL BLOOD MONONUCLEAR CELL;

ADULT; CELLS, CULTURED; CYTOKINES; DEXAMETHASONE; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NF-KAPPA B; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; RESPONSE ELEMENTS; STEROIDS; TRANSCRIPTION FACTOR RELA;

EID: 84855449690     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2011.641977     Document Type: Article

References (36)

1. Cupps TR, Fauci AS. Corticosteroid-mediated immunoregulation in man. Immunol Rev 1982, 65, 133-155. (Pubitemid 12068797)
2. Wrange O, Eriksson P, Perlmann T. Te purifed activated glucocorticoid receptor is a homodimer. J Biol Chem 1989, 264, 5253-5259. (Pubitemid 19092944)
3. Novac N, Baus D, Dostert A, Heinzel T. Competition between glucocorticoid receptor and NFκB for control of the human FasL promoter. FASEB J 2006, 20, 1074-1081. (Pubitemid 44943903)
4. Malkoski SP, Dorin RI. Composite glucocorticoid regulation at a functionally defned negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol Endocrinol 1999, 13, 1629-1644. (Pubitemid 30645269)
5. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994, 91, 752-756. (Pubitemid 24041480)
6. Nissen RM, Yamamoto KR. Te glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 2000, 14, 2314-2329.
7. Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: Importance in infammatory lung diseases. Eur Respir J 2005, 25, 552-563. (Pubitemid 40331188)
8. Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000, 20, 6891-6903.
9. Ayroldi E, Migliorati G, Bruscoli S, Marchetti C, Zollo O, Cannarile L, D'Adamio F, Riccardi C. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor κB. Blood 2001, 98, 743-753.
10. D'Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, Bartoli A, Cannarile L, Migliorati G, Riccardi C. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 1997, 7, 803-812. (Pubitemid 28064893)
11. Barnes PJ. Corticosteroid efects on cell signalling. Eur Respir J 2006, 27, 413-426.
12. Clark AR. MAP kinase phosphatase 1: A novel mediator of biological efects of glucocorticoids? J Endocrinol 2003, 178, 5-12. (Pubitemid 36927003)
13. Yamamoto KR. Steroid receptor regulated transcription of specifc genes and gene networks. Annu Rev Genet 1985, 19, 209-252.
14. Healey LA, Sheets PK. Te relation of polymyalgia rheumatica to rheumatoid arthritis. J Rheumatol 1988, 15, 750-752.
15. van Schaardenburg D, Valkema R, Dijkmans BA, Papapoulos S, Zwinderman AH, Han KH, Pauwels EK, Breedveld FC. Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatment. Arthritis Rheum 1995, 38, 334-342.
16. Seki M, Ushiyama C, Seta N, Abe K, Fukazawa T, Asakawa J, Takasaki Y, Hashimoto H. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efcacy in patients with systemic lupus erythematosus. Arthritis Rheum 1988, 41, 823-830.
17. Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, Jewell DP. Predicting outcome in severe ulcerative colitis. Gut 1996, 38, 905-910. (Pubitemid 26231777)
18. Hearing SD, Norman M, Smyth C, Foy C, Dayan CM. Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. J Clin Endocrinol Metab 1999, 84, 4149-4154. (Pubitemid 30644208)
19. Lane SJ, Arm JP, Staynov DZ, Lee TH. Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma. Am J Respir Cell Mol Biol 1994, 11, 42-48.
20. Hew M, Bhavsar P, Torrego A, Meah S, Khorasani N, Barnes PJ, Adcock I, Chung KF. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006, 174, 134-141. (Pubitemid 44015386)
21. Corrigan CJ, Brown PH, Barnes NC, Tsai JJ, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory efects of glucocorticoids and cyclosporin A. Am Rev Respir Dis 1991, 144, 1026-1032.
22. Leung DY, Martin RJ, Szefer SJ, Sher ER, Ying S, Kay AB, Hamid Q. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med 1995, 181, 33-40.
23. Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma. J Allergy Clin Immunol 2002, 109, 649-657. (Pubitemid 34327193)
24. Bhavsar P, Hew M, Khorasani N, Torrego A, Barnes PJ, Adcock I, Chung KF. Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Torax 2008, 63, 784-790.
25. Adcock IM, Lane SJ, Brown CR, Lee TH, Barnes PJ. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J Exp Med 1995, 182, 1951-1958.
26. Onda K, Rimbara E, Hirano T, Oka K, Abe H, Tahara K, Takanashi H, Tsuboi N, Niitsuma T, Hayashi T. Role of mRNA expression of transcription factors in glucocorticoid sensitivity of peripheral blood mononuclear cells and disease state in rheumatoid arthritis. J Rheumatol 2004, 31, 464-469. (Pubitemid 38337603)
27. Ismaili N, Garabedian MJ. Modulation of glucocorticoid receptor function via phosphorylation. Ann N Y Acad Sci 2004, 1024, 86-101. (Pubitemid 38879595)
28. Hearing SD, Norman M, Probert CS, Haslam N, Dayan CM. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 1999, 45, 382-388. (Pubitemid 29400714)
29. Barnes PJ, Adcock IM. Glucocorticoid resistance in infammatory diseases. Lancet 2009, 373, 1905-1917.
30. Grant IW. Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients. Clin Sci 1984, 67, 639-645.
31. Hermoso MA, Matsuguchi T, Smoak K, Cidlowski JA. Glucocorticoids and tumor necrosis factor α cooperatively regulate toll-like receptor 2 gene expression. Mol Cell Biol 2004, 24, 4743-4756. (Pubitemid 38668041)
32. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, O'Shea JJ, Chrousos G P, Bornstein SR. Gene profling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002, 16, 61-71. (Pubitemid 34027951)
33. McKay LI, Cidlowski JA. Cross-talk between nuclear factor-κB and the steroid hormone receptors: Mechanisms of mutual antagonism. Mol Endocrinol 1998, 12, 45-56. (Pubitemid 28124778)
34. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT. Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinfammatory action of glucocorticoids. Mol Endocrinol 1995, 9, 401-412.
35. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS Jr. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol 1995, 15, 943-953.
36. Ito K, Yamamura S, Essilfe-Quaye S, Cosio B, Ito M, Barnes PJ, Adcock IM. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression. J Exp Med 2006, 203, 7-13. (Pubitemid 43139638)